HIMS — Hims & Hers Health, Inc.
Healthcare · ETF XLV · as of 2026-09-21
Daily · EMA 10 / 20 / 50 · SMA 200 · VolPress: buy/sell split, 20-SMA, white dot = above avg · · E = earnings · RS vs SPY ⓘ · ● RS new high ⓘ
Hims & Hers Health, Inc.
NYQ
Healthcare · Health Care Providers & Services
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Price & today
$29.35
ATR(14) 1.64 (5.59%)
| Stock today | +4.86% |
| Sector ETF today | +0.37% |
| Residual (stock-specific) | +4.49% |
Sector correlation
| 20-day correlation with XLV | 0.03 |
| 60-day correlation with XLV | 0.01 |
| Status | normal |
Decoupling fires when 60d corr − 20d corr > 0.20: stock used to track its sector but the relationship has weakened recently.
Technicals
| 10 EMA | $28.37 |
| 20 EMA | $28.74 |
| 50 EMA | $29.49 |
| EMA stack | BEARISH |
| RSI(14) | 51.4 |
| 52-week high distance | — |
| 52-week low distance | — |
Signals
| Market F&G | 45.6 |
| Bull% | 12.2% |
| OVTLYR status | SELL (13d) |
| Sector rank | #136 |
| Next earnings | 2026-11-02 (TNS, 42d) |
MarketSmith metrics - our compute
RS Rating
61.6
ADR%
5.2
RMV (tight)
45.0
Ext (ATR>20EMA)
0.4
Rel Vol
68.0%
U/D 50d
1.06
U/D 25d
1.42
Accum/Dist 25d
2 / 0
EPS YoY
-134.0%
LoD dist
71.0
Off 52w High
55.1%
Above 52w Low
113.6%
1W / 1M
+1.9 / -7.9
Avg $Vol 50d
375.5M
Mkt Cap (B)
6.8
Trend 8/8
no
Leads Group
no
Sector XLV
+0.8% 1W
Base len (VCP)
23wk (8/1)
Coil (base shape)
85TVPX
not available: float_shares(NULL->no Float%)
What do these abbreviations mean?
- RS Rating
- - IBD-style relative strength vs SPY (weighted 3/6/9/12-mo). 70+ = leaders pool, 80+ = strong.
- ADR%
- - average daily range over 20 days. 4%+ = the fast movers the playbook prefers (selection order, not a gate).
- RMV (tight)
- - Relative Measured Volatility, 15 bars, scaled 0-100. <15 = tight coiled base (green), <35 moderate, high = loose/expanding - not a base right now.
- Ext (ATR>20EMA)
- - how many ATRs price sits above its 20-EMA. ≤1 = in value (green), >2 = extended/chasing (red) - prefer a pullback.
- Rel Vol
- - latest volume vs the 50-day average. 100% = normal; 140%+ = breakout confirmation.
- U/D 50d / 25d
- - up-day vs down-day volume over the window. 1.1+ = net accumulation (institutions buying); under 0.9 on the 25d = net selling.
- Accum/Dist 25d
- - heavy-volume up days vs heavy-volume down days in the last 25 sessions (close moved 0.2%+ on above-average volume). The institutional-participation footprint; 5+ distribution days = O'Neil caution line.
- LoD dist
- - close distance above the day low in % of ATR (100 = one full ATR off the low). High = strong close.
- Off/Above 52w
- - trend-template legs: within 25% of the 52-week high, at least 25% above the 52-week low.
- Trend 8/8
- - all 8 Minervini Trend Template criteria pass. Discovery floor, NOT an entry signal - entries come from the VCP pivot.
- Base len (VCP)
- - weeks since the VCP base started on the latest scan. 10wk+ bases carry the edge; short stacked bases test below random.
Fundamentals & valuation - reference, not entry inputs
P/E (TTM)
-
Fwd P/E
-
PEG
-
Price/Book
-
Profit margin
-
ROE
-
Debt/Equity
-
Rev growth
-
Analyst target
-
Analyst rating
-
Institutional %
-
Insider %
-
Float %
-
Valuation and analyst figures are Yahoo company stats (weekly refresh, ~3,000 larger names - blanks are honest gaps); logo, employees, website and IPO date are Massive company reference. Momentum/VCP entries do not use valuation - this card is context so you do not have to leave the page.
Company data - context read, not entry inputs
Industry rank
25 / 146
Industry
Health Care Providers & Services
Float
-
Float turnover 20d
-
Avg $Vol 20d / 50d
271.4M / 375.5M
Days to cover
-
Short % float
-
Institutional %
-
Weinstein stage
2
Float, short interest and institutional % come from Yahoo company stats, refreshed weekly for ~3,000 larger names - a blank means Yahoo does not publish the figure for this stock, not that it is zero. Dollar volume and float turnover are computed from our own price bars; industry rank from our rotation data; stage from the weekly chart.
Quarterly EPS - earnings acceleration
A dash in %Chg is deliberate: the year-ago figure was a loss, so a growth % would be meaningless. A dash in Sales means we have no revenue figure for that quarter - read it as a gap in our data, not as zero revenue.
| Quarter | EPS ($) | %Chg YoY | Sales ($M) | %Chg |
|---|---|---|---|---|
| Nov-24 | 0.43 | +617% | 401.6 | +77% |
| Feb-25 | 0.23 | - | 481.1 | +95% |
| May-25 | 0.28 | +180% | 586.0 | +111% |
| Aug-25 | 0.29 | +81% | 544.8 | +73% |
| Nov-25 | 0.28 | -35% | 599.0 | +49% |
| Feb-26 | 0.22 | -4% | 617.8 | +28% |
| May-26 | -0.19 | -168% | 608.1 | +4% |
| Aug-26 | -0.10 | -134% | 753.2 | +38% |
† = SEC carries this same fiscal quarter under a second period-end with a materially different figure (hover for it) - a restatement, merger recast or successor-period split; %Chg is blanked when the two are more than 15% apart. It fires only when the two period-ends DISAGREE, so it is a floor, not a guarantee that the rest of the column shares one basis · ‡ = the revenue concept changed from the previous quarter WITH A FIGURE (hover for both) - a blank row in between is skipped, as the eye does - a step at that row is a change of basis, not necessarily of business · EPS = Yahoo
eps_actual (the figure MarketSmith/Deepvue show) - whether a given quarter is GAAP or excludes a one-off follows the filing, so it can sit either side of another vendor's number; AAPL's Oct-24 row, the Sep-2024 fiscal quarter, is $0.97 here - GAAP, including the EU tax charge - where TradingView's year implies $1.64 · Sales ($M) = SEC EDGAR quarterly revenue (fiscal Q4 derived as FY minus 9-mo) · quarter = report month · %Chg blank = prior-year base under $0.05 (not meaningful).Recent news - our DB (Finnhub + OVTLYR)
- Sep 20 − ROSEN, A LEADING LAW FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - HIMS GlobeNewswire Inc.
- Sep 19 − Hims & Hers Health, Inc. Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026, Deadline - Contact Kessler Topaz Meltzer & Check, LLP GlobeNewswire Inc.
- Sep 16 + Is Hims & Hers Stock a Buy Right Now in September? The Motley Fool
- Sep 15 − Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC GlobeNewswire Inc.
- Sep 15 − HIMS Investor Alert: Kessler Topaz Meltzer & Check, LLP Encourages HIMS Investors with Losses to Contact the Firm GlobeNewswire Inc.
- Sep 14 − Shareholders who lost money in shares of acquired Hims & Hers Health, Inc. (NYSE: HIMS) should contact Wolf Haldenstein Immediately GlobeNewswire Inc.
- Sep 14 − Kaplan Fox Alerts Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to a Pending Securities Class Action – Deadline is November 2, 2026 GlobeNewswire Inc.
- Sep 14 − Kaplan Fox Encourages Cogent Communications Holdings, Inc. (NASDAQ: CCOI) Investors Seeking Recovery to Contact the Firm Before September 21, 2026 GlobeNewswire Inc.